Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakazu Haneda

Showing results (21-30 of 213) with videos related to

Pageof 22
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2008
Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?Masakazu Haneda, Akizuki Morikawa
Diabetology International|June 13, 2022
Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveysYukihiro Fujita, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 9, 2016
[Emerging new aspects on diabetic nephropathy]Yumi Takiyama, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Glucose tolerance in renal failure]Atsuko Abiko, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 25, 2003
[Kidney and hypertension]Shin-ichi Araki, Masakazu Haneda
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Progression of diabetic nephropathyRyuichi Kikkawa, Daisuke Koya, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[Clinical utility of angiotensin II receptor antagonist]Shiro Yokohama, Kimihide Nakamura, Masakazu Haneda
Nihon Jinzo Gakkai Shi|November 12, 2011
[HIF-1 in diabetic nephropathy]Yuichi Makino, Tsubasa Isoe, Masakazu Haneda
Current Opinion in Nephrology and Hypertension|November 22, 2014
Dipeptidyl peptidase-4 inhibitors in progressive kidney diseaseYuichi Makino, Yukihiro Fujita, Masakazu Haneda
Journal of Gastroenterology and Hepatology|November 1, 2006
Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytesFuminori Hirano, Masakazu Haneda, Isao Makino
Pageof 22

Showing results (21-30 of 213) with videos related to

Sort By:
Pageof 22
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2008
Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?Masakazu Haneda, Akizuki Morikawa
Diabetology International|June 13, 2022
Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveysYukihiro Fujita, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 9, 2016
[Emerging new aspects on diabetic nephropathy]Yumi Takiyama, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Glucose tolerance in renal failure]Atsuko Abiko, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 25, 2003
[Kidney and hypertension]Shin-ichi Araki, Masakazu Haneda
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Progression of diabetic nephropathyRyuichi Kikkawa, Daisuke Koya, Masakazu Haneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[Clinical utility of angiotensin II receptor antagonist]Shiro Yokohama, Kimihide Nakamura, Masakazu Haneda
Nihon Jinzo Gakkai Shi|November 12, 2011
[HIF-1 in diabetic nephropathy]Yuichi Makino, Tsubasa Isoe, Masakazu Haneda
Current Opinion in Nephrology and Hypertension|November 22, 2014
Dipeptidyl peptidase-4 inhibitors in progressive kidney diseaseYuichi Makino, Yukihiro Fujita, Masakazu Haneda
Journal of Gastroenterology and Hepatology|November 1, 2006
Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytesFuminori Hirano, Masakazu Haneda, Isao Makino
Pageof 22